clinicaltrials.gov dihexa Evidence out, ideology in. The FDA's quiet peptide pivot has nothing to do with the data and everything to do with whose side the regulator is choosing. On April 15, 2026, the Growth Factors and Their Application

Antikaliuretic Therapy or Potassium Supplementation Triamterene and hydrochlorothiazide should not be given to patients receiving other potassium-conserving agents such as spironolactone, amiloride hydrochloride or other formulations containing triamterene

More water means a less concentrated solution that is easier to measure in small doses

Whether preclinical nerve regeneration results translate to equivalent human outcomes is uncertain for all peptides except ARA-290, which has direct human data

Neither EFSA nor the US authorities have set a Tolerable Upper Intake Level for B12, because no consistent harm has been shown from high oral intakes

There is no reason why the particles of each liquid cannot move somewhat freely from one liquid to another, and so they shift toward the most probable (most dispersed), mixed state